- Home
- EVOK vs APDN Comparison
EVOK vs APDN Comparison
Compare EVOK & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVOK
- APDN
- Stock Information
- Founded
- EVOK 2007
- APDN 1983
- Country
- EVOK United States
- APDN United States
- Employees
- EVOK N/A
- APDN N/A
- Industry
- EVOK Biotechnology: Pharmaceutical Preparations
- APDN Other Consumer Services
- Sector
- EVOK Health Care
- APDN Consumer Discretionary
- Exchange
- EVOK Nasdaq
- APDN Nasdaq
- Market Cap
- EVOK 4.2M
- APDN 4.2M
- IPO Year
- EVOK 2013
- APDN N/A
- Fundamental
- Price
- EVOK $2.70
- APDN $4.50
- Analyst Decision
- EVOK
- APDN
- Analyst Count
- EVOK 0
- APDN 0
- Target Price
- EVOK N/A
- APDN N/A
- AVG Volume (30 Days)
- EVOK 19.3K
- APDN 140.8K
- Earning Date
- EVOK 08-12-2025
- APDN 08-07-2025
- Dividend Yield
- EVOK N/A
- APDN N/A
- EPS Growth
- EVOK N/A
- APDN N/A
- EPS
- EVOK N/A
- APDN N/A
- Revenue
- EVOK $11,594,083.00
- APDN $3,790,616.00
- Revenue This Year
- EVOK $57.82
- APDN $57.08
- Revenue Next Year
- EVOK $59.12
- APDN $40.00
- P/E Ratio
- EVOK N/A
- APDN N/A
- Revenue Growth
- EVOK 89.89
- APDN N/A
- 52 Week Low
- EVOK $1.94
- APDN $4.37
- 52 Week High
- EVOK $12.32
- APDN $2,655.00
- Technical
- Relative Strength Index (RSI)
- EVOK 43.42
- APDN 35.16
- Support Level
- EVOK $2.50
- APDN $4.38
- Resistance Level
- EVOK $2.84
- APDN $5.10
- Average True Range (ATR)
- EVOK 0.20
- APDN 0.53
- MACD
- EVOK -0.01
- APDN 0.40
- Stochastic Oscillator
- EVOK 47.45
- APDN 22.32
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About APDN Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.